Alnylam Pharmaceuticals (ALNY) Revenue by Segment

History

Date	Amvuttra	Collaboration	Givlaari	Oxlumo	Royalty	Onpattro
Sep 30, 2025	1.77B	619.37M	286.34M	185.36M	148.04M	197.21M
Jun 30, 2025	1.35B	325.03M	283.46M	172.73M	125.23M	208.43M
Mar 31, 2025	1.09B	490.83M	264.71M	166.46M	107.65M	233.09M
Dec 31, 2024	970.41M	510.15M	255.85M	166.97M	91.79M	252.80M
Sep 30, 2024	859.20M	479.60M	250.50M	156.10M	73.40M	275.70M
Jun 30, 2024	749.30M	849.70M	233.60M	144.60M	59.90M	307.00M
Mar 31, 2024	651.30M	628.20M	229.40M	128.20M	44.70M	321.30M
Dec 31, 2023	557.90M	546.20M	219.20M	109.80M	40.60M	354.60M
Sep 30, 2023	451.20M	540.40M	207.00M	100.90M	26.30M	397.80M
Jun 30, 2023	327.70M	142.20M	198.60M	88.60M	19.10M	461.20M

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.